002826 易明医药
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.37611.9076.1902.0656.035
总资产报酬率 ROA (%)1.8539.5244.9541.5814.790
投入资产回报率 ROIC (%)2.34911.6156.0251.9715.771

边际利润分析
销售毛利率 (%)82.48082.11268.51451.18943.908
营业利润率 (%)13.62715.8139.4343.5246.505
息税前利润/营业总收入 (%)13.42417.8209.0833.3136.435
净利润/营业总收入 (%)10.76214.6367.2802.3585.383

收益指标分析
经营活动净收益/利润总额(%)99.30655.34948.68582.08860.710
价值变动净收益/利润总额(%)0.8163.0765.8209.8002.612
营业外收支净额/利润总额(%)0.11211.487-1.8640.4011.716

偿债能力分析
流动比率 (X)2.7773.2223.0132.8622.195
速动比率 (X)2.5562.9182.7782.5182.021
资产负债率 (%)24.04419.81519.52519.15226.341
带息债务/全部投入资本 (%)0.0720.9942.6401.0426.217
股东权益/带息债务 (%)138,637.7589,903.7423,659.0959,411.0951,495.803
股东权益/负债合计 (%)315.911404.672408.531419.293277.879
利息保障倍数 (X)-61.321-399.550-50.797-14.698-35.132

营运能力分析
应收账款周转天数 (天)8.57014.78218.95951.74741.859
存货周转天数 (天)164.894159.47087.71457.78529.651